Cite
HARVARD Citation
Reiss, K. et al. (2021). Phase II Study of Maintenance Rucaparib in Patients With Platinum-Sensitive Advanced Pancreatic Cancer and a Pathogenic Germline or Somatic Variant in BRCA1, BRCA2, or PALB2. Journal of clinical oncology. 39 (22), pp. 2497-2505. [Online].